Investing.com - Bioventus reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Bioventus announced earnings per share of $0.08 on revenue of $137.07M. Analysts polled by Investing.com EPS of $0.12 on revenue of $141.6M.
Bioventus 's are down 35% and is trading at $3.08 , still down 82.43% from its 52 week high of $17.53 set on Wednesday, November 10, 2021.
Bioventus shares lost 56.44% to trade at $3.08 in intra-day trade the report.
Bioventus follows other major Healthcare sector earnings this month
Bioventus's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar